2025
Selected to Present at the NIKKEI Drug Discovery Summit and Featured in NIKKEI Asia
We are honored to be featured in NIKKEI Asia’s coverage of the NIKKEI Drug Discovery Ecosystem Summit (June 24 […]
FerroptoCure Completes Series A Funding
~Accelerating Development of Next-Generation Cancer Therapies Through Ferroptosis Control~FerroptoCure Inc. (H […]
FerroptoCure CEO Yuji Otsuki Featured on TV Tokyo’s “Breakthrough”
FerroptoCure Inc. (Headquarters: Tokyo, Japan; CEO: Yuji Otsuki) is pleased to announce that its CEO, Yuji Ots […]
FerroptoCure Selected for the AMED “Strengthening Program for Pharmaceutical Startup Ecosystem”
FerroptoCure Inc. (Headquarters: Tokyo, Japan; CEO: Yuji Otsuki) is pleased to announce that it has been selec […]
FerroptoCure Inc. Selected for Vision Award at 2025 FemCareTech Conference
https://www.nttdata.com/jp/ja/lineup/hcclab/bizcon202503 FerroptoCure Inc, is happy to announce that Yuji Otsu […]
FerroptoCure Selected for Tokyo Venture Championship
FerroptoCure has been selected to pitch at the Tokyo Venture Championship on March 12th, 2025. Find out more i […]
FerroptoCure Nominated for Nippon Innovation Award
We are honored to be nominated for the NIPPON INNOVATION AWARD and NIPPON INNOVATION TRYOUT!&nb […]
FerroptoCure On Display at TiB Yurakucho Station
Our CEO, Yuji Otsuki, was presented with an award at the TIB PITCH Global Event, there is a FerroptoCure booth […]
FerroptoCure Singled out for Success By CIC in 2024 Review
From: https://cic.com/blog/one-year-later-2023-global-startup-acceleration-program-gsap/ FerroptoCure is deter […]